HomeTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Nakaraang pagsara
₹636.40
Sakop ng araw
₹631.00 - ₹642.70
Sakop ng taon
₹506.80 - ₹722.65
Market cap
33.93B INR
Average na Volume
75.79K
P/E ratio
47.40
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 1.54B | 13.52% |
Gastos sa pagpapatakbo | 603.60M | 67.39% |
Net na kita | 177.80M | 42.58% |
Net profit margin | 11.53 | 25.60% |
Kita sa bawat share | 3.54 | 50.00% |
EBITDA | 325.02M | 43.91% |
Aktuwal na % ng binabayarang buwis | 24.98% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 1.77B | 26.11% |
Kabuuang asset | 6.44B | 1.76% |
Kabuuang sagutin | 1.16B | 19.23% |
Kabuuang equity | 5.28B | — |
Natitirang share | 50.23M | — |
Presyo para makapag-book | 6.07 | — |
Return on assets | — | — |
Return on capital | 9.39% | — |
Cash Flow
Net change in cash
(INR) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 177.80M | 42.58% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
1,645